EP-104IAR
EP-104IAR-101
Phase 1 small_molecule completed
Quick answer
EP-104IAR for Osteoarthritis, Knee is a Phase 1 program (small_molecule) at EUPRAXIA PHARMACEUTICALS INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- EUPRAXIA PHARMACEUTICALS INC.
- Indication
- Osteoarthritis, Knee
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed